Back
Celldex Therapeutics Vs. Electromed Industry Stock Comparison
Buy
57
CLDX
Celldex Therapeutics
Last Price:
41.15
Seasonality Move:
-0.32%
Buy
65
ELMD
Electromed
Last Price:
20.49
Seasonality Move:
0.31%
Buy
57
Celldex Therapeutics (CLDX)
is a Buy
Is Celldex Therapeutics a Buy, Sell or Hold?
- The current Celldex Therapeutics [CLDX] share price is $41.16. The Score for CLDX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- CLDX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Electromed (ELMD)
is a Buy
Is Electromed a Buy, Sell or Hold?
- The current Electromed [ELMD] share price is $20.34. The Score for ELMD is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- ELMD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CLDX Stock Price Chart
What is Celldex Therapeutics's stock price today?
-
The Celldex Therapeutics share price today is $41.16
The current trend is moderately bullish and CLDX is experiencing selling pressure, which indicates risk of future bearish movement.
ELMD Stock Price Chart
What is Electromed's stock price today?
-
The Electromed share price today is $20.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ELMD is experiencing slight buying pressure.
CLDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.35 | Buy |
| Relative Strength Index (14 RSI): | 53.55 | Buy |
| Chaikin Money Flow: | -800851 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.49 - 43.11) | Buy |
| Bollinger Bands (100): | (34.53 - 40.97) | Buy |
ELMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.08 | Buy |
| Relative Strength Index (14 RSI): | 73.93 | Buy |
| Chaikin Money Flow: | 28655 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CLDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.09 | Sell |
| 20-day SMA: | 41.02 | Buy |
| 50-day SMA: | 38.45 | Buy |
| 200-day SMA: | 38.71 | Buy |
| 8-day EMA: | 41.89 | Sell |
| 20-day EMA: | 40.84 | Buy |
| 50-day EMA: | 39.09 | Buy |
| 200-day EMA: | 37.54 | Buy |
ELMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.45 | Buy |
| 20-day SMA: | 17.07 | Buy |
| 50-day SMA: | 15.87 | Buy |
| 200-day SMA: | 14.39 | Buy |
| 8-day EMA: | 18.69 | Buy |
| 20-day EMA: | 17.45 | Buy |
| 50-day EMA: | 16.32 | Buy |
| 200-day EMA: | 14.62 | Buy |
Celldex Therapeutics Earnings Growth & CLDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.19 per share, and a decrease next year of $0.66 per share.
Electromed Earnings Growth & ELMD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Celldex Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Electromed Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||